Aries Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $667K | Hold |
9,548
| – | – | 0.17% | 113 |
|
2025
Q1 | $702K | Sell |
9,548
-30
| -0.3% | -$2.21K | 0.19% | 111 |
|
2024
Q4 | $628K | Hold |
9,578
| – | – | 0.17% | 122 |
|
2024
Q3 | $746K | Sell |
9,578
-892
| -9% | -$69.5K | 0.21% | 106 |
|
2024
Q2 | $817K | Hold |
10,470
| – | – | 0.26% | 97 |
|
2024
Q1 | $709K | Hold |
10,470
| – | – | 0.23% | 100 |
|
2023
Q4 | $705K | Sell |
10,470
-9
| -0.1% | -$606 | 0.25% | 93 |
|
2023
Q3 | $711K | Buy |
10,479
+633
| +6% | +$42.9K | 0.28% | 89 |
|
2023
Q2 | $705K | Hold |
9,846
| – | – | 0.27% | 93 |
|
2023
Q1 | $683K | Hold |
9,846
| – | – | 0.28% | 91 |
|
2022
Q4 | $668K | Hold |
9,846
| – | – | 0.29% | 90 |
|
2022
Q3 | $579K | Sell |
9,846
-184
| -2% | -$10.8K | 0.26% | 95 |
|
2022
Q2 | $663K | Buy |
+10,030
| New | +$663K | 0.3% | 76 |
|
2022
Q1 | – | Sell |
-10,030
| Closed | -$584K | – | 83 |
|
2021
Q4 | $584K | Sell |
10,030
-1,441
| -13% | -$83.9K | 0.22% | 100 |
|
2021
Q3 | $689K | Buy |
11,471
+431
| +4% | +$25.9K | 0.29% | 81 |
|
2021
Q2 | $661K | Sell |
11,040
-655
| -6% | -$39.2K | 0.28% | 83 |
|
2021
Q1 | $583K | Buy |
11,695
+1,665
| +17% | +$83K | 0.26% | 88 |
|
2020
Q4 | $510K | Hold |
10,030
| – | – | 0.25% | 89 |
|
2020
Q3 | $550K | Hold |
10,030
| – | – | 0.31% | 79 |
|
2020
Q2 | $530K | Hold |
10,030
| – | – | 0.32% | 76 |
|
2020
Q1 | $439K | Hold |
10,030
| – | – | 0.33% | 74 |
|
2019
Q4 | $500K | Hold |
10,030
| – | – | 0.31% | 77 |
|
2019
Q3 | $437K | Hold |
10,030
| – | – | 0.29% | 86 |
|
2019
Q2 | $411K | Hold |
10,030
| – | – | 0.29% | 91 |
|
2019
Q1 | $406K | Hold |
10,030
| – | – | 0.3% | 80 |
|
2018
Q4 | $381K | Hold |
10,030
| – | – | 0.4% | 67 |
|
2018
Q3 | $397K | Hold |
10,030
| – | – | 0.36% | 72 |
|
2018
Q2 | $392K | Hold |
10,030
| – | – | 0.36% | 75 |
|
2018
Q1 | $368K | Hold |
10,030
| – | – | 0.36% | 77 |
|
2017
Q4 | $355K | Buy |
+10,030
| New | +$355K | 0.33% | 83 |
|